{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:48:44Z","timestamp":1793501324638,"version":"4.5.0"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Motor neuron disease includes a heterogeneous group of relentless progressive neurological disorders defined and characterized by the degeneration of motor neurons. Amyotrophic lateral sclerosis is the most common and aggressive form of motor neuron disease with no effective treatment so far. Unfortunately, diagnostic and prognostic biomarkers are lacking in clinical practice. Neurofilaments are fundamental structural components of the axons and neurofilament light chain and phosphorylated neurofilament heavy chain can be measured in both cerebrospinal fluid and serum. Neurofilament light chain and phosphorylated neurofilament heavy chain levels are elevated in amyotrophic lateral sclerosis, reflecting the extensive damage of motor neurons and axons. Hence, neurofilaments are now increasingly recognized as the most promising candidate biomarker in amyotrophic lateral sclerosis. The potential usefulness of neurofilaments regards various aspects, including diagnosis, prognosis, patient stratification in clinical trials and evaluation of treatment response. In this review paper, we review the body of literature about neurofilaments measurement in amyotrophic lateral sclerosis. We also discuss the open issues concerning the use of neurofilaments clinical practice, as no overall guideline exists to date; finally, we address the most recent evidence and future perspectives.<\/jats:p>","DOI":"10.4103\/1673-5374.308072","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T15:09:31Z","timestamp":1613660971000},"page":"1985-1991","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":27,"title":["Current application of neurofilaments in amyotrophic lateral sclerosis and future perspectives"],"prefix":"10.4103","volume":"16","author":[{"given":"Yuri Matteo","family":"Falzone","sequence":"first","affiliation":[{"name":"Neuropathology Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy"},{"name":"Neurology and Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Russo","sequence":"additional","affiliation":[{"name":"Neuropathology Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy"},{"name":"Neurology and Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teuta","family":"Domi","sequence":"additional","affiliation":[{"name":"Neuropathology Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pozzi","sequence":"additional","affiliation":[{"name":"Neuropathology Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Quattrini","sequence":"additional","affiliation":[{"name":"Neuropathology Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Filippi","sequence":"additional","affiliation":[{"name":"Neurology and Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy"},{"name":"Neurophysiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy"},{"name":"Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy"},{"name":"Vita-Salute San Rafaele University, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0513-9517","authenticated-orcid":false,"given":"Nilo","family":"Riva","sequence":"additional","affiliation":[{"name":"Neuropathology Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy"},{"name":"Neurology and Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,10]]},"reference":[{"key":"R1-20260526","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neurobiolaging.2017.05.024","article-title":"Structural and functional brain signatures of C9orf72 in motor neuron disease","volume":"57","author":"Agosta","year":"2017","journal-title":"Neurobiol Aging"},{"key":"R2-20260526","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12974-020-01737-0","article-title":"Increased serum neurofilament light chain concentration indicates poor outcome in Guillain-Barre syndrome","volume":"17","author":"Altmann","year":"2020","journal-title":"J Neuroinflammation"},{"key":"R3-20260526","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.18632\/aging.101551","article-title":"YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression","volume":"10","author":"Andres-Benito","year":"2018","journal-title":"Aging (Albany NY)"},{"key":"R4-20260526","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ana.25276","article-title":"Neurofilament light: a candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion","volume":"84","author":"Benatar","year":"2018","journal-title":"Ann Neurol"},{"key":"R5-20260526","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1212\/WNL.0000000000009559","article-title":"Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS","volume":"95","author":"Benatar","year":"2020","journal-title":"Neurology"},{"key":"R6-20260526","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/joim.12816","article-title":"Biomarkers for Alzheimer\u2019s disease: current status and prospects for the future","volume":"284","author":"Blennow","year":"2018","journal-title":"J Intern Med"},{"key":"R7-20260526","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/jnnp-2012-303768","article-title":"Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis","volume":"84","author":"Boylan","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R8-20260526","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"R9-20260526","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00415-016-8313-y","article-title":"Factors predicting survival in ALS: a multicenter Italian study","volume":"264","author":"Calvo","year":"2017","journal-title":"J Neurol"},{"key":"R10-20260526","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/acn3.779","article-title":"Neurofilament as a potential biomarker for spinal muscular atrophy","volume":"6","author":"Darras","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"R11-20260526","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/ane.13078","article-title":"Comparison of plasma and cerebrospinal fluid neurofilament light in a multiple sclerosis trial","volume":"139","author":"de Flon","year":"2019","journal-title":"Acta Neurol Scand"},{"key":"R12-20260526","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/jnnp-2017-316605","article-title":"Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"89","author":"De Schaepdryver","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R13-20260526","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/acn3.50890","article-title":"Serum neurofilament heavy chains as early marker of motor neuron degeneration","volume":"6","author":"De Schaepdryver","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"R14-20260526","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13024-019-0318-4","article-title":"The role of neurofilament aggregation in neurodegeneration: lessons from rare inherited neurological disorders","volume":"14","author":"Didonna","year":"2019","journal-title":"Mol Neurodegener"},{"key":"R15-20260526","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1007\/s00415-020-09838-9","article-title":"Serum phosphorylated neurofilament heavy-chain levels reflect phenotypic heterogeneity and are an independent predictor of survival in motor neuron disease","volume":"267","author":"Falzone","year":"2020","journal-title":"J Neurol"},{"key":"R16-20260526","doi-asserted-by":"crossref","first-page":"7789","DOI":"10.1007\/s12035-018-0947-6","article-title":"Towards a TDP-43-based biomarker for ALS and FTLD","volume":"55","author":"Feneberg","year":"2018","journal-title":"Mol Neurobiol"},{"key":"R17-20260526","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1212\/WNL.0000000000004761","article-title":"Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis","volume":"90","author":"Feneberg","year":"2018","journal-title":"Neurology"},{"key":"R18-20260526","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jamaneurol.2016.5398","article-title":"Diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis: neurofilament light chain levels in definite subtypes of disease","volume":"74","author":"Gaiani","year":"2017","journal-title":"JAMA Neurol"},{"key":"R19-20260526","doi-asserted-by":"crossref","first-page":"e75091","DOI":"10.1371\/journal.pone.0075091","article-title":"Increased neurofilament light chain blood levels in neurodegenerative neurological diseases","volume":"8","author":"Gaiottino","year":"2013","journal-title":"PLoS One"},{"key":"R20-20260526","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ana.24980","article-title":"Phosphorylated neurofilament heavy chain: A biomarker of survival for C9ORF72-associated amyotrophic lateral sclerosis","volume":"82","author":"Gendron","year":"2017","journal-title":"Ann Neurol"},{"key":"R21-20260526","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3389\/fnins.2019.00601","article-title":"The peripheral nervous system in amyotrophic lateral sclerosis: opportunities for translational research","volume":"13","author":"Gentile","year":"2019","journal-title":"Front Neurosci"},{"key":"R22-20260526","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/nan.12511","article-title":"Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with amyotrophic lateral sclerosis","volume":"45","author":"Gille","year":"2019","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R23-20260526","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ebiom.2015.11.036","article-title":"Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: a cross-sectional study","volume":"3","author":"Gisslen","year":"2016","journal-title":"EBioMedicine"},{"key":"R24-20260526","doi-asserted-by":"crossref","first-page":"17085","DOI":"10.1038\/nrdp.2017.85","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"R25-20260526","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brainres.2017.05.011","article-title":"Serum concentrations of the axonal injury marker neurofilament light protein are not influenced by blood-brain barrier permeability","volume":"1668","author":"Kalm","year":"2017","journal-title":"Brain Res"},{"key":"R26-20260526","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1002\/acn3.50943","article-title":"Combined use of CSF NfL and CSF TDP-43 improves diagnostic performance in ALS","volume":"6","author":"Kasai","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"R27-20260526","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1515\/cclm-2015-1195","article-title":"Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA electrochemiluminescence immunoassay and Simoa","volume":"54","author":"Kuhle","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"R28-20260526","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1212\/WNL.0000000000001491","article-title":"Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis","volume":"84","author":"Kuhle","year":"2015","journal-title":"Neurology"},{"key":"R29-20260526","first-page":"1352458519885613","article-title":"Neurofilament light levels are associated with long-term outcomes in multiple sclerosis","author":"Kuhle","year":"2019","journal-title":"Mult Scler"},{"key":"R30-20260526","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.3390\/ijms21082911","article-title":"Abeta1-42 and Tau as potential biomarkers for diagnosis and prognosis of amyotrophic lateral sclerosis","volume":"21","author":"Lanznaster","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R31-20260526","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3389\/fneur.2018.00726","article-title":"Diagnostic performance of neurofilaments in Chinese patients with amyotrophic lateral sclerosis: a prospective study","volume":"9","author":"Li","year":"2018","journal-title":"Front Neurol"},{"key":"R32-20260526","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/jamaneurol.2016.6179","article-title":"Serum C-reactive protein as a prognostic biomarker in amyotrophic lateral sclerosis","volume":"74","author":"Lunetta","year":"2017","journal-title":"JAMA Neurol"},{"key":"R33-20260526","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41586-020-2625-x","article-title":"C9orf72 in myeloid cells suppresses STING-induced inflammation","volume":"585","author":"McCauley","year":"2020","journal-title":"Nature"},{"key":"R34-20260526","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.expneurol.2017.03.008","article-title":"Potassium channel abnormalities are consistent with early axon degeneration of motor axons in the G127X SOD1 mouse model of amyotrophic lateral sclerosis","volume":"292","author":"Maglemose","year":"2017","journal-title":"Exp Neurol"},{"key":"R35-20260526","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12883-018-1091-7","article-title":"TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"18","author":"Majumder","year":"2018","journal-title":"BMC neurology"},{"key":"R36-20260526","doi-asserted-by":"crossref","first-page":"e028486","DOI":"10.1136\/bmjopen-2018-028486","article-title":"Proteostasis and ALS: protocol for a phase II randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS)","volume":"9","author":"Mandrioli","year":"2019","journal-title":"BMJ Open"},{"key":"R37-20260526","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/jns.12279","article-title":"Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies","volume":"23","author":"Mariotto","year":"2018","journal-title":"J Peripher Nerv Syst"},{"key":"R38-20260526","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1172\/JCI99081","article-title":"Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models","volume":"128","author":"McCampbell","year":"2018","journal-title":"J Clin Invest"},{"key":"R39-20260526","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/acn3.212","article-title":"CSF neurofilament light chain reflects corticospinal tract degeneration in ALS","volume":"2","author":"Menke","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"R40-20260526","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.reth.2019.07.002","article-title":"Ropinirole hydrochloride remedy for amyotrophic lateral sclerosis - Protocol for a randomized double-blind, placebo-controlled, single-center, and open-label continuation phase I\/IIa clinical trial (ROPALS trial)","volume":"11","author":"Morimoto","year":"2019","journal-title":"Regen Ther"},{"key":"R41-20260526","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jns.2014.06.003","article-title":"Delayed diagnosis in ALS: the problem continues","volume":"343","author":"Nzwalo","year":"2014","journal-title":"J Neurol Sci"},{"key":"R42-20260526","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1172\/JCI71601","article-title":"Emerging mechanisms of molecular pathology in ALS","volume":"125","author":"Peters","year":"2015","journal-title":"J Clin Invest"},{"key":"R43-20260526","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1212\/WNL.0000000000004029","article-title":"Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease","volume":"88","author":"Poesen","year":"2017","journal-title":"Neurology"},{"key":"R44-20260526","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00415-016-8091-6","article-title":"Recent advances in amyotrophic lateral sclerosis","volume":"263","author":"Riva","year":"2016","journal-title":"J Neurol"},{"key":"R45-20260526","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ana.22110","article-title":"Motor nerve biopsy: clinical usefulness and histopathological criteria","volume":"69","author":"Riva","year":"2011","journal-title":"Ann Neurol"},{"key":"R46-20260526","doi-asserted-by":"crossref","first-page":"e518","DOI":"10.1212\/WNL.0000000000004932","article-title":"Plasma neurofilament light chain concentration in the inherited peripheral neuropathies","volume":"90","author":"Sandelius","year":"2018","journal-title":"Neurology"},{"key":"R47-20260526","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1007\/s00415-018-9043-0","article-title":"Significance of CSF NfL and tau in ALS","volume":"265","author":"Schreiber","year":"2018","journal-title":"J Neurol"},{"key":"R48-20260526","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/21678421.2016.1241279","article-title":"Diagnostic and prognostic significance of neurofilament light chain NF-L but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net","volume":"18","author":"Steinacker","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"R49-20260526","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1136\/jnnp-2019-320442","article-title":"CSF chitinase proteins in amyotrophic lateral sclerosis","volume":"90","author":"Thompson","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R50-20260526","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/ene.14063","article-title":"Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis","volume":"27","author":"Thouvenot","year":"2020","journal-title":"Eur J Neurol"},{"key":"R51-20260526","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/j.1468-1331.2012.03777.x","article-title":"Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression","volume":"19","author":"Tortelli","year":"2012","journal-title":"Eur J Neurol"},{"key":"R52-20260526","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/jnnp-2018-318704","article-title":"Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis","volume":"90","author":"Verde","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R53-20260526","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/jnnp-2019-321916","article-title":"Cross-sectional and longitudinal measures of chitinase proteins in amyotrophic lateral sclerosis and expression of CHI3L1 in activated astrocytes","volume":"91","author":"Vu","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R54-20260526","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S1474-4422(18)30089-9","article-title":"Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model","volume":"17","author":"Westeneng","year":"2018","journal-title":"Lancet Neurol"},{"key":"R55-20260526","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ana.24552","article-title":"Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis","volume":"79","author":"Weydt","year":"2016","journal-title":"Ann Neurol"},{"key":"R56-20260526","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1515\/cclm-2019-0015","article-title":"Correlations between serum and CSF pNfH levels in ALS FTD and controls: a comparison of three analytical approaches","volume":"57","author":"Wilke","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"R57-20260526","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000493986","article-title":"Cerebrospinal fluid neurofilaments may discriminate upper motor neuron syndromes: a pilot study","volume":"18","author":"Zucchi","year":"2018","journal-title":"Neurodegener Dis"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.308072","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:31:57Z","timestamp":1786735917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.308072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,19]]},"references-count":57,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/1673-5374.308072","relation":{},"ISSN":["1673-5374","1876-7958"],"issn-type":[{"value":"1673-5374","type":"print"},{"value":"1876-7958","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,19]]},"assertion":[{"value":"2020-07-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}